Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

RNA modifications help heal wounds and could lead to new treatments.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Phospholipase A2 enzymes play key roles in skin health and disease.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Skin bacteria help heal wounds and restore healthy skin.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Tetracycline can stick to hair follicles and potentially cause hair loss.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Lymphangiosarcoma was confirmed in cats with specific skin symptoms using a lymphatic marker.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Metabolic syndrome may increase the risk of small cell lung cancer.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Nestin helps identify certain melanoma cells in nodular melanoma.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.